Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases
- 1 June 2007
- journal article
- other
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 13 (5) , 676-678
- https://doi.org/10.1177/1352458506073502
Abstract
Autologous hematopoietic stem cell transplantation (AHSCT) has been proposed as a rescue treatment in multiple sclerosis (MS) patients not responding to first- or second-line therapies. To date, most of the treated cases had a secondary progressive disease course. However, patients with high inflammatory activity, but no secondary progression of the disease, could be candidates to take greater advantage of AHSCT. In this paper, we report two cases with very active, relapsing-remitting (RR) MS, who underwent AHSCT, and obtained a dramatic resolution to disease activity. Multiple Sclerosis 2007; 13: 676-678. http://msj.sagepub.comKeywords
This publication has 8 references indexed in Scilit:
- Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of lifeBlood, 2005
- Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patientsThe Journal of Experimental Medicine, 2005
- Autologous haematopoietic-stem-cell transplantation for multiple sclerosisPublished by Elsevier ,2005
- Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experienceJournal of the Neurological Sciences, 2004
- Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MSNeurology, 2001
- MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MSNeurology, 2001
- Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot FoundationZeitschrift für Neurologie, 2000
- Rating neurologic impairment in multiple sclerosisNeurology, 1983